Contact l Sitemap

home industries issues reasearch weblog press

Home  » Issues » Regulation

Regulation : Displaying 11-20 of 45


Toyota May Pay $1 Billion To Settle Unintentional Accelerations Claims
by Richard SmallteacherCorpWatch Blog
February 17th, 2014
Toyota is expected to announce a billion dollar settlement with the U.S. government for failing to disclose complaints by drivers that its cars were accelerating unintentionally. News of the negotiations were reported by the Wall Street Journal.

Anglo Irish Bankers On Trial For Scheme That Led to National Collapse
by Pratap ChatterjeeCorpWatch Blog
February 12th, 2014
Three top executives at Anglo Irish bank are on trial for a secret scheme to buy their own bankís shares that eventually triggered the 2008 collapse of the Irish economy. The bankers allegedly hatched the plan to cover up bets made by Sean Quinn, once Irelandís richest man.

Ranbaxy Pays $500 Million Fine for Selling Bad Batches of Generic Medicines
by Pratap ChatterjeeCorpWatch Blog
May 14th, 2013
Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has paid a $500 million fine and pled guilty to selling adulterated drugs manufactured in India. The settlement comes 16 months after the company signed an agreement with U.S. authorities to change its ways.

Neither Admit Nor Deny: Big Business Allowed To Pay Millions to Avoid Jail
by Pratap ChatterjeeCorpWatch Blog
May 5th, 2013
Record fines adding up to $36 billion have been paid out in the last 12 years by multinational corporations to the U.S. government to settle charges of corruption and fraud. But are they getting away with a slap on the wrist to avoid prosecution for major crimes?

Monsanto Bullies Small Farmers Over Planting Harvested GMO Seeds
by Puck LoCorpWatch Blog
March 24th, 2013
Does Monsanto own all future generations of genetically modified seeds that it sells? The Missouri-based agribusiness giant wants farmers to pay a royalty to plant any seed that descended from a patented original. The legal decision has ramifications for other patented "inventions" that reproduce themselves like strands of DNA.

Starbucks: Espresso for Investors, Watery Americano in UK Taxes
by Pratap ChatterjeeCorpWatch Blog
October 26th, 2012
Starbucks, the Seattle-based international coffee chain, has been accused of tax avoidance in the UK. Between 1998 and 2011 the company has made £3 billion in sales but paid out just £8.6 million in taxes on sales from its 735 stores in the country.

Seven Irish Banks Investigated for Insurance Scam
by Pratap ChatterjeeCorpWatch Blog
October 8th, 2012
Seven Irish banks are being investigated by the Central Bank of Ireland for selling consumers insurance policies that they did not need. Tens of thousands of Irish consumers could get as much as Ä3,000 ($3,900) each in refunds.

Fake Drug Plague or Pharmaceutical Industry Attack on Generics?
by Pratap ChatterjeeCorpWatch Blog
June 13th, 2012
Are Africa and South East Asia just suffering from a deluge of fake medicines that is causing disease resistance to rise? Or are they also suffering from a deluge of poorly informed media articles, encouraged by the pharmaceutical industry that wants to make war on generic drugs?

Unsticking Food Lobbyists in Europe
by Pratap ChatterjeeCorpWatch Blog
March 6th, 2012
The European Food Safety Authority has approved new rules that will ban industry experts from serving on EFSA scientific panels related to their work. Corporate Europe Observatory says the rules are still not strong enough

The True Cost of Chevron: An Alternative Annual Report
by Antonia JuhaszTrue Cost of Chevron
May 25th, 2010
Chevron's 2009 Annual Report celebrates 130 years of Chevron operations. We, the communities and our allies who bear the consequences of Chevron's offshore drilling rigs, oil and natural gas production, coal fields, refineries, depots, pipelines, exploration, chemical plants, political control, consumer abuse, false promises, and much more, have a very different account to offer.